These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37516634)

  • 1. microRNAs in parasite-induced liver fibrosis: from mechanisms to diagnostics and therapeutics.
    Liu M; Cho WC; Flynn RJ; Jin X; Song H; Zheng Y
    Trends Parasitol; 2023 Oct; 39(10):859-872. PubMed ID: 37516634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III.
    He X; Wang Y; Fan X; Lei N; Tian Y; Zhang D; Pan W
    J Hepatol; 2020 Mar; 72(3):519-527. PubMed ID: 31738999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling.
    Hyun J; Jung Y
    World J Gastroenterol; 2016 Aug; 22(29):6652-62. PubMed ID: 27547008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA- and miRNA-based therapeutics for liver fibrosis.
    Zhao Z; Lin CY; Cheng K
    Transl Res; 2019 Dec; 214():17-29. PubMed ID: 31476281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA function in the profibrogenic interplay upon chronic liver disease.
    Huang J; Yu X; Fries JW; Zhang L; Odenthal M
    Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.
    Chen SL; Zheng MH; Shi KQ; Yang T; Chen YP
    BioDrugs; 2013 Feb; 27(1):25-34. PubMed ID: 23329398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGE
    Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA interplay between hepatic stellate cell quiescence and activation.
    Ezhilarasan D
    Eur J Pharmacol; 2020 Oct; 885():173507. PubMed ID: 32858048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    Knabel MK; Ramachandran K; Karhadkar S; Hwang HW; Creamer TJ; Chivukula RR; Sheikh F; Clark KR; Torbenson M; Montgomery RA; Cameron AM; Mendell JT; Warren DS
    PLoS One; 2015; 10(4):e0124411. PubMed ID: 25923107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of liver cirrhosis.
    Zhou WC; Zhang QB; Qiao L
    World J Gastroenterol; 2014 Jun; 20(23):7312-24. PubMed ID: 24966602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.
    Liu X; Ma H; Wu R; Wang H; Xu H; Li S; Wang G; Lv G; Niu J
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.
    Su Q; Kumar V; Sud N; Mahato RI
    Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
    Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
    J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
    Wu B; Feng J; Guo J; Wang J; Xiu G; Xu J; Ning K; Ling B; Fu Q; Xu J
    Stem Cell Res Ther; 2022 Oct; 13(1):494. PubMed ID: 36195966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNAs-based diagnostic and therapeutic applications in liver fibrosis.
    Zhao X; Xue X; Cui Z; Kwame Amevor F; Wan Y; Fu K; Wang C; Peng C; Li Y
    Wiley Interdiscip Rev RNA; 2023; 14(4):e1773. PubMed ID: 36585388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice.
    Hong JS; Lee DH; Yook YW; Na D; Jang YJ; Kim JH; Lee YS
    Biosci Biotechnol Biochem; 2017 Jul; 81(7):1348-1355. PubMed ID: 28372490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
    Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T
    Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.
    Huang CF; Sun CC; Zhao F; Zhang YD; Li DJ
    J Gastroenterol; 2015 Apr; 50(4):480-90. PubMed ID: 25155445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.
    Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J
    Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.